Teladoc Health TDOC

Mr. Charles Divita III, Interim Principal Financial Officer, Director and Chief Executive Officer. Career highlights: TELADOC HEALTH, INC. Chief Executive Officer and Director (2024 to present) Interim Principal Financial Officer (2025 to present) GUIDEWELL MUTUAL HOLDING CORPORATION, a leading not-for-profit, policyholder-owned health solutions organization Executive Vice President, Commercial Markets (2018 to 2024) Senior Vice President, Chief Financial Officer (2014 to 2018) Various leadership positions (2011 to 2014); FPIC INSURANCE GROUP, a property and casualty insurance company Chief Financial Officer (2006 to 2011) Various leadership positions (2000 to 2006). Other current directorships: Vim (2025 to present; also served 2021 to 2024). Prior directorships: Availity (2018 to 2024); Prime Therapeutics (2018 to 2024). Education: Bachelor of Science in Accounting and Finance, Florida State University. Credentials: Certified Public Accountant. Charles Divita III transitioned out of the role of Interim Chief Financial Officer, effective 31st August 2026.

Mr. Carlos Nueno, President, International. Career highlights: TELADOC HEALTH, INC. President, International (2018 to present) Mr. Nueno is responsible for the strategic direction, operations and client management for the company's global footprint. ADVANCE MEDICAL Co-founder, CEO (1999 to its acquisition by Teladoc Health in 2018); GEMINI CONSULTING Consultant (1999 to 2000) Other current directorships: Barcelona Global, Supervisory Board Member. Education: Master of Business Administration, IESE Business School, Spain; Bachelor's degree, Industrial and Mechanical Engineering, Polytechnic University of Catalonia, Spain.

Ms. Kelly Bliss, President, U.S. Group Health. Career highlights: TELADOC HEALTH, INC. President, U.S. Group Health (2020 to present) Ms. Bliss oversees strategy, partnerships, product management, marketing, sales, operations, and client management as lead executive for our U.S. Group Health business. Chief Client Officer (2017 to 2020); BEST DOCTORS Chief of Staff (2016 to its acquisition by Teladoc Health in 2017); Vice President (2014 to 2016); Other current directorships: Federal Reserve Bank Second District, Advisory Council Member. Education: Bachelor's degree in Industrial Psychology, Nichols College.

Mr. Adam C. Vandervoort, Chief Legal Officer and Secretary. Career highlights: TELADOC HEALTH, INC. Chief Legal Officer and Secretary (2015 to present) Mr. Vandervoort helps us comply with applicable laws and serves as secretary to our Board. He is responsible for all of our legal matters, including government affairs, corporate governance, securities law, intellectual property, and privacy, as well as all human resources functions; INDEPENDENCE HOLDING COMPANY Corporate Vice President, General Counsel and Secretary (2006 to 2015); PAUL HASTINGS LLP Associate Attorney in Corporate Practice (2004 to 2006); FEDEX CORPORATION Staff Attorney (2002 to 2004); SULLIVAN & CROMWELL LLP; Associate Attorney in Corporate Practice (1999 to 2002). Recognitions: Admitted to practice law in the states of California, Connecticut and New York; Member, Board of Education, Stamford, Connecticut (2026 to Present); Served on the Municipal Board of Ethics, Stamford, Connecticut. Education: J.D., University of Pennsylvania Law School; AM and AB, University of Chicago.

Mr. Kenneth H. Paulus, Chairman of the Board. Career highlights PRIME THERAPEUTICS, one of the nation's largest pharmacy benefit managers President, Chief Executive Officer and Director (2019 to 2023) ALLINA HEALTH, one of the nation's largest not-for-profit integrated delivery systems Various executive leadership roles including, President, Chief Executive Officer and Chief Operating Officer (2005 to 2014) ATRIUS HEALTH SYSTEM, one of the largest integrated physician organizations in New England and a teaching affiliate of Harvard Medical School President and Chief Executive Officer (2005 to 2009) PARTNERS COMMUNITY HEALTH CARE Chief Operating Officer (1994 to 2000). Other current directorships: Gravie Health; Compliance Solutions (Chair). Prior directorships: Breg (2017 to 2024); AllyAlign Health (2017 to 2021); Cogentix Medical (2015 to 2016); Team Health (2015 to 2016). Education: Master of Healthcare Administration and Management, University of Minnesota BA in Biology, Augustana College.

Mr. David L. Shedlarz, Independent Director. Career highlights: PFIZER, INC., a pharmaceutical company Former Vice Chair (2005 to 2007); Executive Vice President and Chief Financial Officer having worldwide responsibility for Pfizer's former Medical Technology Group (1999 to 2005); Played key role in shaping the strategic direction that contributed to Pfizer's impressive growth and helped establish it as an industry leader and innovator. Prior directorships: Pitney Bowes, Inc. (2001 to 2023); The Hershey Company (2008 to 2021); TIAA (2007 to 2021). Education: MBA, Finance and Accounting, New York University, Leonard N. Stern School of Business; BS in Economics and Mathematics, Michigan State University-Oakland.

Ms. Catherine A. Jacobson, Independent Director. Career highlights: FROEDTERT THEDACARE HEALTH, a regional health care system based in Milwaukee, Wisconsin Chief Executive Officer and Director (2024); President, Chief Executive Officer and Director (2012 to 2023); President (2011-2012); Executive Vice President of Finance and Strategy, Chief Financial Officer and Chief Strategy Officer (2010-2011); RUSH UNIVERSITY MEDICAL CENTER; Various executive leadership roles including CFO, treasurer, SVP of finance and strategic planning, marketing and communications (1988 to 2010). Other current directorships and engagements: Vice Chair, Vizient Bradley University Siebert Lutheran Foundation Prior directorships Wisconsin Hospital Association (2012 to 2024) Mercy Health (2014 to 2019); Chair, Metropolitan Milwaukee Association of Commerce (2021 to 2022). Recognitions: Gail L. Warden Leadership Excellence Award of the National Center for Healthcare Leadership (2024); Modern Healthcare, Top 25 Women Leaders (2021-2022); Modern Healthcare, 100 Most Influential People in Healthcare (2019, 2022 and 2023); Junior Achievement of Wisconsin, Distinguished Executives of the Year (2018) and induction into the Wisconsin Business Hall of Fame. Education: Bachelor of Science in Accounting, Bradley University; Honorary Degree-Doctor of Healthcare Leadership, University of Wisconsin- Milwaukee.

Dr. Mark Douglas Smith, M.B.A.,M.D., Independent Director. Career highlights: UNIVERSITY OF CALIFORNIA AT SAN FRANCISCO Clinical professor of medicine (1994 to present); SAN FRANCISCO GENERAL HOSPITAL Board-certified internist and maintains a clinical practice in HIV care (1994 to present); GUIDING COMMITTEE OF THE HEALTH CARE PAYMENT LEARNING AND ACTION NETWORK, a public-private partnership launched by the U.S. Department of Health and Human Services to promote the transition to value-based payment to improve care quality while lowering costs Co-chair (2015 to 2019); CALIFORNIA HEALTH CARE FOUNDATION, an independently endowed philanthropy that works to improve healthcare access and quality for Californians Founding President and Chief Executive Officer, helped build the foundation into a recognized leader in delivery system innovation, public reporting of care quality and applications of new technology in healthcare (1996 to 2013) Other current public company boards Jazz Pharmaceuticals plc; Phreesia, Inc. Other current directorships and engagements: Commonwealth Fund; Editorial Board, Health Affairs; Prealize Health. Education: M.D., University of North Carolina at Chapel Hill; MBA with a concentration in health care administration, Wharton School, University of Pennsylvania; Bachelor's degree in Afro-American Studies, Harvard College.

Ms. Sandra L. Fenwick, Independent Director. Career highlights: BOSTON CHILDREN'S HOSPITAL, the nation's foremost independent pediatric hospital and the world's leading center of pediatric medical and health research Chief Executive Officer, where she was a driving force to improve the effectiveness and efficacy of the care provided at Boston Children's, while at the same time reducing the cost of care (2013 to 2021) President (2008 to 2013); Chief Operating Officer (1999 to 2008); Senior Vice President (1999). Other current directorships and engagements: Harvard's Wyss Institute for Biologically Inspired Engineering, Inc.; Risk Management Foundation of the Harvard Medical Institutions, Inc.; Patient Discovery, Inc.; BCH Foundation UK Limited; Member, Massachusetts Women's Forum; Member, Women Corporate Directors Boston. Prior directorships: Livongo Health, Inc. (2019 to the Teladoc Health/Livongo merger in 2020). Education: Ms. Fenwick has received numerous awards and five honorary degrees for her contributions to healthcare; Master's in Public Health in Health Services Administration, University of Texas School of Public Health; Bachelor's degree, with distinction, Simmons University.

Jonathan Dorfman, currently the Company's Senior Vice President, Securities & Corporate Law, will assume the role of Chief Legal Officer and Secretary of the Company effective on November 1, 2026. Dorfman joined Teladoc Health in 2020 through the acquisition of Livongo, where he led SEC compliance and corporate governance. He has served in legal roles of increasing responsibility at Teladoc Health, most recently leading the company's SEC reporting and disclosure, corporate governance, capital markets and mergers and acquisitions. Previously, Dorfman was an in-house lawyer at USG Corporation and practiced law at Sidley Austin LLP.

Prior to joining the Company, Mr. Grasher served from February 2024 to September 2025 as Chief Financial Officer of IFG Companies, a privately held multi-line excess and surplus lines insurance company, where he was responsible for financial reporting, planning and analysis, and treasury management. Previously, Mr. Grasher served from October 2015 to February 2024 as Chief Financial Officer and Executive Vice President of the Fortegra Group, a global specialty insurer, where he oversaw financial governance and accounting across the company's U.S. and European operations, among other duties. Earlier, Mr. Grasher served as Chief Financial Officer and Executive Vice President of AMERISAFE, Inc., a publicly traded workers' compensation insurer, where he led financial reporting, capital management and investor relations. Mr. Grasher was also previously an equity research analyst covering insurance companies on both the buy and sell side, and brings a deep understanding of the public markets. Mr. Grasher holds a Masters of Business Administration from the University of Chicago Booth School of Business and a Bachelor of Science from the University of Illinois.

Effective August 3, 2026, the Board of Directors of Teladoc Health, Inc. appointed Mark V. Anquillare as a director of the Company. Mr. Anquillare is the former president and chief operating officer of Verisk Analytics, a strategic data analytics and technology partner to the global insurance industry. Mr. Anquillare has more than 30 years of financial and executive leadership experience. He served as Verisk's chief financial officer beginning in 2007, leading the company through its 2009 initial public offering, and later served as Verisk's chief operating officer, overseeing the company's insurance and government-facing business as well as several corporate functions. Throughout his career, Mr. Anquillare has helped companies drive growth, innovation and operating efficiency. He currently serves on the board of Guidewire Software where he chairs the audit committee and is a member of the business opportunities committee. He also serves on the boards of RegEd and Bamboo Insurance, and he previously served on the board of TruBridge. Mr. Anquillare holds an MBA from Rutgers Business School and a BBA from the University of Notre Dame.

Mr. Fernando Madeira, President, BetterHelp. Career highlights: TELADOC HEALTH, INC. President, BetterHelp (2023 to present) Mr. Madeira is responsible for strategic direction, business growth, service operations, partnerships and product development for BetterHelp, our direct-to-consumer mental health service. IPSY President (2018 to 2022) WALMART; President and CEO, Walmart.com (2014 to 2017); President and CEO, Latin America eCommerce (2012 to 2014) TERRA Co-founder and CEO (1989 to 2012). Education: Bachelor of Computer Science, Pontifical Catholic University of Rio Grande do Sul, Brazil.

Teladoc Health, the global leader in virtual care, today announced the appointment of Susan Salka to its board of directors, effective March 30, 2026. Ms. Salka is the former president and CEO of AMN Healthcare Services, a provider of healthcare workforce technology solutions and staffing services to healthcare facilities across the US. During her 33-year tenure at AMN Healthcare, Ms. Salka was one of the driving forces behind the company's strategic and operational success. AMN pioneered the evolution of workforce solutions and made 26 acquisitions to meet the changing needs of clients, transforming the company and growing revenue to over $5 billion. Ms. Salka currently serves on the board of Parexel International and previously served on the boards of McKesson Corporation, Beckman Coulter and Playtex Products. She holds an MBA in Finance from San Diego State University and a BA in Accounting and Economics from Chadron State College.

Effective September 9, 2024, Joseph Catapano joined Teladoc Health, Inc. as its Chief Accounting Officer. Mr. Catapano, previously served as Vice President, Chief Accounting Officer of Pitney Bowes Inc. from August 2017 to September 2024. In this role, he served as the Company's principal accounting officer. He served as Interim Chief Financial Officer from November 2020 to February 2021 and as Vice President and Controller of Pitney Bowes from 2008 until 2017. Prior to 2008, Mr. Catapano served as Vice President of Finance for Pitney Bowes' mailing businesses in the U.S., Canada and South America and also served in positions of increasing responsibility in the Corporate Controller's group since joining Pitney Bowes in 1997. Prior to joining Pitney Bowes, Mr. Catapano held finance positions with PepsiCo Inc. and was an Audit Manager with KPMG Peat Marwick where he spent six years serving multinational companies. He is a Certified Public Accountant in the state of Connecticut. He holds a BS in Financial Accounting from the University of New Haven and a certificate in Executive Education from the Darden School of Business at the University of Virginia.

Mr. Michael S. Smith has been appointed to the board as Independent Director with effect from 18th Feb 2026. Mr. Smith is the former Vice Chair and Chief Financial Officer of Voya Financial, a leading health, wealth, and investment company, where he played an integral role in the company's transformation from a traditional insurance business to a market leader in retirement, investment and workplace benefits. He held senior executive roles in Actuarial, Finance, Operations and Risk Management during more than 20 years at Lincoln Financial. He currently serves as Executive Chairman of Talcott Financial Group, an international life insurance and risk management firm with $130 billion in assets under management. Mr. Smith holds an undergraduate degree from the University of Michigan, is a Fellow of the Society of Actuaries, and is a CFA charterholder.